UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 NOTICE OF EFFECTIVENESSEffective Date:April 06,
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 15 CERTIFI...
As filed with the Securities and Exchange Commission on March 31, 2021 Registration No. 333-226699 &nb...
NOTIFICATION OF REMOVAL FROM LISTING AND/OR REGISTRATION UNDER SECTION 12(b) OF THE SECURITIES EXCHANGE ACT OF 1934. Commission File...
Filed by 4D Pharma plc pursuant to Rule 425 under the Securities Act of 1933 Form F-4 File No.:...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C...
Longevity Acquisition Corporation Announces Results of Special Meeting of Shareholders PR Newswire NEW YORK, March 18, 2021 NEW YORK, March 18...
Filed by 4D Pharma plc pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule...
Filed by 4D Pharma plc pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.